Previous 10 | Next 10 |
2023-06-14 10:03:06 ET Gainers: Inventiva ( IVA ) +25% . Gossamer Bio ( GOSS ) +21% . Akoya Biosciences ( AKYA ) +19% . InVivo Therapeutics ( NVIV ) +14% . Bone Biologics ( BBLG ) +13% . Losers: IO Biotech ( IOBT ...
Brett Swansiger joins as Chief Commercial Officer Karen Miller PhD joins as Chief Scientific Officer GUILDFORD, SURREY / ACCESSWIRE / June 5, 2023 / ANGLE plc ("the Company") (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, is delighted to announce the appointments of Br...
CPC and agilon are committed to accelerating access to value-based care to improve health outcomes for senior patients For the first time, agilon’s Total Care Model expands to Eastern Georgia within the CSRA The Center for Primary Care (CPC), an independent practice dedic...
2023-05-30 10:18:25 ET Jefferies tapped nine themes and then ran a quant screen on factors that fit their strategy best. It came up with 19 names, but with a twist. "We decided to use our quant model and factors to determine our themes and in the end, we came away with 19 Buy rated ...
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 43 rd Annual William Blair Growth Stock Conference including a presentation on Wednesday, June 7, at 1:40PM Eastern Time. A sim...
Pharma Services Contract Win Parsortix DNA Damage Response Assays developed by ANGLE to be used for exploratory objectives in a Phase 1 clinical trial Trial expected to complete by year end 2024 GUILDFORD, SURREY / ACCESSWIRE / May 25, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a worl...
GUILDFORD, SURREY / ACCESSWIRE / May 22, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company announces that Garth Selvey has informed the Board of his intention to retire and leave ANGLE at the publication of the 2023 Interims in September. Garth will hand over the Cha...
2023-05-16 07:23:51 ET agilon health ( NYSE: AGL ) prices of its previously announced underwritten secondary public offering of ~86.88M shares at a public offering price of $21.50 per share. Underwriters have a 30-day option to purchase up to an additional ~7.73M shares. ...
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced the launch of an underwritten secondary public offering of 70,000,000 shares of its common stock by the selling stockholder, CD&R Vector Holdings, L.P., an a...
2023-05-13 19:43:05 ET agilon health, inc. (AGL) Q1 2023 Results Conference Call May 09, 2023 04:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Lisa Gill - JPMorgan George Hil...
News, Short Squeeze, Breakout and More Instantly...
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2024 after the market closes on Tuesday, August 6, 2024, and host a conference call at 4:30 PM Easter...
Dr. Rao to Continue to Lead Clinical Strategy and Drive Physician Network Performance Alongside agilon’s Chief Clinical Officer Kevin Spencer, M.D. agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced ...
2024-07-07 00:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...